NEU vs SSRM

NEU exhibits strong fundamental health with a Piotroski F-Score of 7/9 and robust liquidity, but it is currently trading at a significant premium to its deterministic value. The current price of $675.62 far exceeds both the Graham Number ($430.75) and the growth-based Intrinsic Value ($306.46). While profitability remains high with an ROE of 25.27%, the company is facing a growth contraction with negative YoY revenue and earnings growth. Consequently, the stock appears overvalued despite its operational quality.

With a Piotroski F-Score of 4/9, SSRM exhibits stable financial health, though the absence of an Altman Z-Score leaves a gap in bankruptcy risk quantification. The stock is currently priced at $31.75, trading at a premium to its Graham Number ($26.82) but significantly below its growth-based Intrinsic Value ($54.58). While the company shows explosive YoY earnings growth and a very low forward P/E of 6.13, the 'Çöpler Incident' noted in the 10-K represents a critical qualitative risk. Despite a bearish technical trend score, the fundamental valuation and analyst consensus suggest strong upside potential.